Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Solana Company (NASDAQ: HSDT) Releases Investor Update
-
BlossomHill Therapeutics to Present at the 67th American Society of Hematology (ASH) Annual Meeting on Design of Phase 1/1b Study of BH-30236, an Oral Macrocyclic CLK Inhibitor, in R/R AML or HR-MDS
-
Dubai Chambers Announces Speaker Lineup and Program for Dubai Business Forum – USA in New York City on November 12, 2025
-
Oxbridge / SurancePlus Provide Performance Update on 2025/26 Tokenized Reinsurance Offerings
-
Ontomir (OTM), a Layer 1 Blockchain, Listed on BitMart Exchange
-
NewGen Announces Proposed Reverse Merger with SAXA, Inc. in a $5 Billion Mining Asset Acquisition Deal, Involving Gold, Silver, and Rare Earth
-
Mutuum Finance (MUTM) Attracts Nearly 18,000 Investors Ahead of a 20% Price Jump
-
Flare Therapeutics to Participate in Upcoming Investor Conferences in November
-
Infoblox Surpasses 200 Customers in Breakout Year for Universal DDI™ and Announces New Capabilities for Network Transformation
-
Collage Group Announces Leadership Transition: Kevin Daly Appointed CEO; Co-Founder David Wellisch to Serve as Executive Chairman
-
Stride, Inc. Authorizes $500 Million Stock Repurchase Program
-
Gevo Makes First Delivery of Certified Carbon Credits to Biorecro, Unlocking Value from Carbon as a Co-Product
-
Lyell Announces Two Oral Presentations from the Phase 1/2 Clinical Trial of Ronde-Cel for the Treatment of Aggressive Large B-Cell Lymphoma at the 67th ASH Annual Meeting and Exposition
-
Fullstory acquires Usetiful, turning digital insights into decisive actions
-
Wandercraft Gains Second FDA Indication Extension for Atalante X in Less Than Two Years, Extending Advanced Robotic Rehabilitation for More Patients with Severe Mobility Loss
-
Phosphorus Declares Independence from Opaque CPS Security Pricing and Passive Discovery Vendors
-
Disc Medicine Announces Presentation of Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
-
Gymboree and New York City Ballet Partner on a Magical Nutcracker-Inspired Holiday Capsule Collection
-
Scripps Howard Fund invests record-breaking $1.8 million to provide books for children at low-income schools
-
Flywire Appoints Nicole James as Chief People Officer
-
Editas Medicine Announces EDIT-401 Poster Presentation at the American Heart Association (AHA) Scientific Sessions 2025
-
Finacity Facilitates US$20 million 5-year Term Securitization for Crediapoyo
-
Claude can now run instant research with GWI
-
Jerry Evans named President of SDI LaFarga COPPERWORKS
-
Beam Therapeutics to Present Updated Data from BEACON Phase 1/2 Trial of BEAM-101 in Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting
-
Personal Finance Expert and Bestselling Author Jade Warshaw Reveals the Emotional Side of Money in New Book “What No One Tells You About Money,” Now Available for Presale
-
Octaura Expands Management Team, Appoints Cristina Kim as Chief Financial Officer
-
Muscular Dystrophy Association Honors National Family Caregivers Month with Advocacy and Awareness Nationwide
-
Aktsiaselts Infortar Investor Webinar introducing the results of the Q3 2025
-
SalMar - Invitation to presentation of the third quarter 2025 results
-
Turnover of Apranga Group in October 2025
-
Evaxion expands R&D pipeline with new AI-designed precision cancer vaccine candidate
-
Roche to present new data from its broad and innovative haematology portfolio at ASH 2025
-
Nokia and Rohde & Schwarz collaborate on AI-powered 6G receiver to cut costs, accelerate time to market
-
Inspiring the Next Generation: National Skilled Trade and Technology Week Launches Across Canada
-
Plymouth Rock Assurance Brings Humor and Humanity to Insurance with New “Keep Calm and Rock On” Brand Campaign
-
AIM ImmunoTech Announces European Patent Office Grants Patent Covering Ampligen® (Rintatolimod) for Use in the Treatment of the Post-COVID Condition of Fatigue
-
Form 8.3 - Dalata Hotel Group plc
-
Form 8.3 - Frenkel Topping Group plc - Octopus Investments
-
Shell plc Commences Any and All Exchange Offers for Six Series of USD Notes Issued by Shell International Finance B.V. and BG Energy Capital plc
-
FrankCrum Expands Health Insurance Offerings with New Florida Blue Regional Master Plan
-
SUTNTIB AB Tewox publishes its NAV for October 2025
-
Form 8.3 - IDOX plc - Octopus Investments
-
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025
-
VivoPower Enters Heads of Agreement with KOSDAQ Listed KWeather to Launch Initial US$5 Million XRP Focused Digital Asset Reserve & WeatherCoin Tokenization Project in South Korea
-
First Commonwealth Financial Corporation Appoints Joseph V. DiVito Jr. to Board of Directors
-
Exodus Movement, Inc. to Announce Third Quarter 2025 Results on November 10, 2025
-
VivoPower Enters Heads of Agreement with KOSDAQ Listed KWeather to Launch Initial US$5 Million XRP Focused Digital Asset Reserve & WeatherCoin Tokenization Project in South Korea
-
Worksport ($WKSP) to Showcase SOLIS™ and COR™ at SEMA 2025, Expanding Global Distribution Opportunities
-
Immix Biopharma’s NXC-201 NEXICART-2 Clinical Trial Results Selected for Oral Presentation at ASH 2025
